Genome mining utilizes bioinformatics to analyze microbial genomic data, predicting and identifying cryptic natural product biosynthetic gene clusters (e.g., NRPS, PKS). Coupled with heterologous expression and structural characterization, it discovers compounds with novel structures and activities (e.g., antibiotics, antitumor agents), overcoming traditional cultivation limits and accelerating drug resource exploration.